Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors.
about
Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model.Dual roles for immune metagenes in breast cancer prognosis and therapy prediction.A standardized and reproducible protocol for serum-free monolayer culturing of primary paediatric brain tumours to be utilized for therapeutic assays.Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.Characterization of distinct immunophenotypes across pediatric brain tumor types.Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.Microenvironmental clues for glioma immunotherapy.Vaccine-based immunotherapy for glioblastoma.MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR.CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages.Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors.Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study.Integrated genomic analysis of survival outliers in glioblastoma.NKG2D ligand expression in pediatric brain tumors.EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain.Emerging evidence of anti-tumor immune control in the central nervous system.Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response.Leukocyte telomere length: a novel biomarker to predict the prognosis of glioma patients.Clinical and immunological correlates of long term survival in glioblastoma.Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples.Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathwayAngiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma
P2860
Q34152633-9A596871-E8BA-4EE3-9C13-41F6E857559FQ34558758-58A3F4E7-4194-4E95-939C-FA0595DD54B4Q35860191-693A6470-28F3-4E97-8099-B8E197CDB8A7Q36545074-0B5D2A80-08D0-49B0-A7B5-93FD8BCDC030Q37308164-25910CCD-36CD-4D3E-A14F-88A2E72EE327Q37687506-4D0110B2-E46E-4993-B448-DD3A471DE1ECQ38194054-04F4A6A4-CB24-4E9E-8C29-68F1521A1B62Q38233114-244C2EFD-EF28-4F1A-8718-25308B4B8045Q38652482-C9A52E65-58BB-4495-9518-D23406273502Q38783257-DF3B9230-8529-4117-9D67-BCFEFACF78AFQ38809641-080B5DA7-2190-4945-BC2F-1010F473D9EEQ39100186-E7C5F5F8-414B-4246-B390-A23880B48ECDQ39118060-9EFD1374-67CD-49F0-90B8-5375C01BC931Q39196323-7EF050E7-17B1-487E-BA15-F901A27D588CQ40089704-798FCDBF-A5C4-428B-91FB-0E71F965CF94Q40990401-1E0C1541-1570-4944-8CCF-F29F4A6AD352Q42417726-94CEE301-25E9-4AFB-B3ED-1B22F8AD0E21Q47660305-6058F020-70B0-4F7E-BE80-AB09B906A367Q53601991-67B7A476-5454-4826-8E15-F9E0D360FAB0Q55021849-5962706F-7E4B-4E0D-B4D5-281FFA9CB495Q55457206-9D696FF5-130E-46EC-8DA5-3FC96DEB73DEQ55461100-6A4972B6-9558-4E55-9888-5EA2D4CD8FA2Q57116103-2A217B3C-3C70-4FC3-98E9-19F71914B900Q58701542-C894C17B-7DCF-486D-A6E1-147DDE2AD638
P2860
Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Increased immune gene expressi ...... erm from short-term survivors.
@ast
Increased immune gene expressi ...... erm from short-term survivors.
@en
type
label
Increased immune gene expressi ...... erm from short-term survivors.
@ast
Increased immune gene expressi ...... erm from short-term survivors.
@en
prefLabel
Increased immune gene expressi ...... erm from short-term survivors.
@ast
Increased immune gene expressi ...... erm from short-term survivors.
@en
P2093
P2860
P356
P1476
Increased immune gene expressi ...... term from short-term survivors
@en
P2093
Allen E Waziri
Andrew M Donson
Bette K Kleinschmidt-DeMasters
Derrick Y Sun
Diane K Birks
Michael H Handler
Michael Wang
Molly F Hemenway
Stephanie A Schittone
P2860
P304
P356
10.4049/JIMMUNOL.1103373
P407
P577
2012-07-16T00:00:00Z